Aduhelm Approval Is Breakthrough For Neurimmune, Company Which Discovered It

Royalties Will Fuel R&D Expansion

 
• By Andrew McConaghie

The co-founder of the Swiss company which discovered aducanumab looks back over its 20 year wait for approval, and ahead to future growth plans.

University of Zurich
Neurimmune was launched as a spin-out from the University of Zurich in 2006. • Source: Alamy

More from Neurological

More from Therapy Areas